Effects of Pioglitazone on Adiponectin and Inflammatory Markers in Overweight or Obese Hemodialysis Patients: A Double-Blinded Randomized Controlled Trial
Phase of Trial: Phase IV
Latest Information Update: 05 Oct 2016
At a glance
- Drugs Pioglitazone (Primary)
- Indications Insulin resistance; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 07 Jun 2017 Biomarkers information updated
- 09 Aug 2016 Status changed from recruiting to completed.
- 18 Apr 2013 Status changed from completed to recruiting as reported by ClinicalTrials.gov.